The General Pharmaceutical Council (GPhC) has strongly condemned recent acts of racism, violence, and disorder caused by far-right, anti-immigrant protestors
across the UK.
Roz Gittins, chief pharmacy officer at GPhC, expressed deep concern for the safety of pharmacy teams, particularly those from Black and minority ethnic backgrounds.
He said: "We strongly condemn the racism, violence and disorder caused by a small minority of the population that has taken place over recent days."
"We understand that pharmacy teams serving our communities may feel especially vulnerable at this time."
"Pharmacists and pharmacy technicians from black and minority ethnic backgrounds, as well as those who trained abroad, make an enormous contribution to our
pharmacy and health services and they should never have to feel fear when going to work.
The British Medical Association (BMA) has urged non-GP partners and contractors, including pharmacists, nurses, and physiotherapists, to support their
"Protect Your Patients, Protect Your GP Practice" campaign, which was launched to protest changes to the 2024/25 GP contract.
GP contractors and partners across England have strongly opposed the modifications to the GMS contract, leading to an ongoing dispute with the NHS.
The BMA highlights that general practice in England currently receives just 6 pence of every NHS pound and an average GMS 'global sum' of £107.57 per registered
patient annually.
Since 2018/19, CPI erosion to the GMS contract has resulted in a loss of £659 million, or 6.6%. This financial strain has contributed to the closure or merger
of over 1,300 practices over the past decade.
To address these issues, the BMA is urging all GP contractors and partner members to vote YES in the GPC England non-statutory ballot, which will be open
until July 29.
The Leverhulme Trade Charities Trust (LTCT) is set to provide financial aid for the families of those working in the convenience, grocery, and pharmacy
trades starting next month.
In an announcement, the Trust shared that the applications for the academic year 2024/25 for undergraduate bursaries will start from August 1 till October 15.
LTCT bursary schemes are intended for university students whose parent or carer is "employed in an eligible profession, such as convenience retailer, supermarket
store worker, or pharmacy technician".
According to the charity's bursary scheme, successful applicants can receive up to £3,000, which can be put towards tuition fees, course materials, equipments, or
even travel costs.
"With the charity's core belief that everyone should have the opportunity to reach their academic potential", LTCT believes.
The bursary scheme will help alleviate some of the financial pressure on students interested in pursuing higher education and their parents.
In 2024, the total number of bursaries awarded since the scheme launched is expected to exceed 5,000, totalling £28million worth of financial aid.
At the recent 'Locum Matters' online event held on June 25, 2024, members of the Pharmacists' Defence Association (PDA) discussed critical issues facing
locum pharmacists, with a disturbing trend taking center stage: employers pressuring locum pharmacists to accept lower rates under the threat of potential pharmacy
closures.
The event, organised in response to feedback from PDA locum members, addressed a range of significant topics including training for the recent Pharmacy First
Services, respect for professional autonomy, and the need for adequate rest breaks.
However, the issue of rate pressure and pharmacy closures was a focal point.
Several locum pharmacists reported that some employers were leveraging the possibility of pharmacy closures to coerce them into working for lower pay.
This unethical practice has raised alarm within the locum community, highlighting the precarious working conditions many face.
A snap survey conducted by the National Pharmacy Association (NPA) revealed that over half of community pharmacy teams have felt unsafe in the past week
due to ongoing riots across the country.
The survey, which included responses from approximately 350 community pharmacies, also found that one in three pharmacies had considered closing because of
safety concerns, while 13 per cent of pharmacy teams reported experiencing racist comments during this period.
According to the NPA, over 40 per cent of pharmacists are of South Asian, Black, or other ethnic minority backgrounds, with the majority of independent community
pharmacy owners believed to be of South Asian heritage.
The association reports that businesses had been vandalised during the riots, leading some pharmacies to reduce their opening hours or close entirely, following
advice from the police and local authorities.
Despite a recent decline in disorder over the last few days, police have been advised to remain on high alert over the weekend.
NHS England has funded the Centre for Pharmacy Postgraduate Education (CPPE) to offer 80 free places in their Accuracy Checking Pharmacy Technician (ACPT)
programme.
Starting August 2024, up to 10 NHSE-funded places will be available each month on a first-come, first-served basis for pharmacy technicians working in community
pharmacy, NHS hospitals, and in health and justice.
The funding will continue until all 80 places are allocated or until March 2025.
CPPE has revealed that 50 per cent of the funding has been allocated for community pharmacy and 50 per cent for other sectors.
The ACPT programme is a 3-12 month course aimed at helping pharmacy technicians achieve various competencies, ensuring they can provide safe and effective patient
care.
"Not improving our funding is not an option, if they want to continue to deliver anything like the level of patient care we have done in recent years," he
emphasised as he prepares for the NPA'S Save Our Pharmacies Day of Action (June 20).
Over the past two years, McElrea has navigated crises stemming from NHS Scotland policies, particularly concerning medicines price inflation and delayed payments.
"The cost of medicines increased rapidly compared to inflation," McElrea stated, noting NHS Scotland's slow response in adjusting tariff prices.
"This wiped out £50,000 of cash reserves and forced us into £30,000 of additional borrowings."
Delayed payments further strained operations, with McElrea highlighting the impact of payments based on outdated pricing.
In a powerful display of unity, thousands of pharmacies across the UK participated in a nationwide protest today, organised by the National Pharmacy
Association (NPA), as part of its #saveourpharmacies campaign.
The NPA's day of action was aimed at drawing attention to the severe crisis in pharmacy funding that has forced 1,400 pharmacies to close over the past decade
and left thousands more struggling.
Participating pharmacies showed their protest through various actions like dimming lights, blacking out their windows, wearing black for the day, or discussing
pharmacy funding with customers. Many pharmacies also seized the opportunity to interact with parliamentary candidate, urging them to address the funding crisis.
In a surprising move that has divided the pharmacy profession, the General Pharmaceutical Council (GPhC) has sanctioned hundreds of pharmacies to allow
patients to self-select certain Pharmacy (P) medicines, a decision met with strong opposition from the Royal Pharmaceutical Society (RPS) as well as from the
Pharmacy Defense Association (PDA).
In a statement, RPS shared that at a board meeting held on 19th June, they expressed "disappointment" over what they described as a lack of prior consultation
and comprehensive communication from the GPhC regarding the implications of this policy shift.
They argue that allowing patients to self-select certain P medicines could potentially jeopardize established professional guidelines and compromise the role of
pharmacists in ensuring safe medication use.
"Enabled by the General Pharmaceutical Council, we understand that hundreds of pharmacies, from large multiples to small independents, have been approved by the
regulator to enable patients to self-select certain P medicines," the statement said.
The World Health Organization (WHO) issued a warning on Thursday regarding falsified semaglutide medications used for treating type 2 diabetes and obesity
in select countries.
This WHO Medical Product Alert addresses three falsified batches of the specific brand Ozempic that were detected in Brazil (October 2023), the United Kingdom
and Northern Ireland (October 2023), and the United States (December 2023). These falsified semaglutide products were distributed through the regulated supply chain.
Novo Nordisk, the genuine manufacturer of Ozempic, confirmed that the three products mentioned in the alert are falsified and were not produced by the company.
Healthcare professionals, regulatory authorities and the public are advised to remain vigilant regarding these falsified batches of medicines.
Dr Yukiko Nakatani, WHO Assistant Director-General for Access to Medicines and Health Products, urged stakeholders to stop any usage of suspicious medicines and
report them to relevant authorities.
On June 3, Synnovis, a pathology laboratory serving several NHS organisations in South East London, was targeted by a ransomware attack.
This cyber incident has disrupted vital blood testing services, crucial for a range of medical treatments, and raised significant concerns over data security.
NHS England confirmed that a cybercriminal group, Qilin, published data online, claiming it was stolen from Synnovis.
The National Crime Agency (NCA) and the National Cyber Security Centre (NCSC) are currently working to authenticate the data and understand its contents.
A helpline has been established to address patient concerns, and NHS England urges patients to attend their appointments unless otherwise directed.
The attack has rendered some of the NHS's blood testing systems inoperable, causing substantial disruption to medical services in South East London.
In a unified effort to improve women's healthcare, four leading organisations-the Company Chemists' Association (CCA), the National Pharmacy Association (NPA),
the Royal Pharmaceutical Society (RPS), and the Faculty of Sexual and Reproductive Healthcare (FSRH)-are calling for the commissioning of a National Emergency
Hormonal Contraception (EHC) service in England.
They are proposing that this service be provided free of charge through community pharmacies to women of all ages across the country.
They emphasised that such a service would "not only transform access to care for all women, but directly tackle health inequalities and vastly improve health
outcomes."
"Only around half of ICSs have a Chief Pharmacist," indicating a significant gap in leadership that hampers the pharmacy sector's ability to influence
critical healthcare decision, a report on medicine optimisation by the Public Policy Projects (PPP) highlights.
In PPP's latest report, a notable concern highlighted is the inadequate representation of pharmacy leadership within Integrated Care Systems (ICSs) despite the
role of pharmacy being "central in the delivery of system priorities, with pivotal roles in improving population health and tackling inequalities".
In recent years, the role of pharmacy within the NHS has evolved significantly with recent developments including Pharmacy First Services and legislative
amendments that allows pharmacy technicians under PGDs to administer and supply medicines.
A recently published report on medicines optimisation highlights the urgent need for transformative changes across all pharmacies to unlock their full
potential in delivering integrated care.
The report by Public Policy Projects (PPP) is first of the four in the series that emphasises the significant benefits that medicines optimisation can bring to
integrated care systems (ICSs).
This includes reducing health inequalities and improving population health.
Pointing to the "untapped opportunity" that medicines optimisation presents for ICSs facing financial challenges, the report underscores the vital role of
pharmacies in enhancing patient outcomes.
The launch of the Pharmacy First services has already demonstrated the essential contribution of pharmacies to the health and care system.
With "medicines being the second highest cost to the NHS," the report recommends ways "to achieve better value for money while improving patient outcomes".
A judicial review claim launched by the British Medical Association (BMA) against the General Medical Council (GMC) has parallelly intensified Pharmacists'
Defence Association's (PDA) scrutiny over the use of the term 'pharmacy professionals'.
PDA has criticised the evolving definition of 'pharmacy professionals,' and the potential risks to patient safety amidst regulatory ambiguity as part of "a far
wider agenda."
Concerns stem from what the PDA perceives as a blurring of distinctions between pharmacists and pharmacy technicians as "attempted homogenisation" by bodies like
the General Pharmaceutical Council (GPhC), NHS, and Royal Pharmaceutical Society (RPS).
Raising similar issue as the BMA against the GMC over its use of 'medical professionals for doctors and Medical Associate Professions (MAPs), Mark Koizol,
Chairman of the PDA has said:
The business landscape worldwide is undergoing a significant transformation, shifting from a sole focus on profitability to incorporating a broader spectrum
of considerations. Today, Environmental, Social, and Governance (ESG) criteria are integral to business operations, reflecting a commitment to sustainable and
ethical practices alongside financial growth.
ESG stands for three interconnected pillars: Environmental, focusing on reducing a company's ecological footprint; Social, addressing the impact on employees,
diversity, equity, inclusion, and the broader community; and Governance, which ensures responsible management practices, ethical behavior, and compliance with
regulations.
This holistic approach is becoming a critical foundation for long-term success in various industries, including healthcare. For the UK healthcare and pharmacy
sectors, integrating ESG not only aligns with global sustainability goals but also offers substantial benefits. This article delves into the specific implications
of ESG for UK pharmacies, highlighting how they can leverage these practices to foster both community well-being and business success.
As the general election campaign continues, Labour is set to introduce a series of policies aimed at supporting small businesses.
On Saturday, Sir Keir Starmer, alongside shadow chancellor Rachel Reeves and other shadow cabinet ministers, is expected to unveil the party's plans for the sector.
Key proposals include an overhaul of the business rates system to enable high street shops to compete with online giants and ensure access to high street
banking services by accelerating the establishment of banking hubs.
Labour will also commit to addressing the issue of late payment of invoices by requiring large businesses to disclose their payment practices and "revitalise" high
streets by tackling antisocial behaviour.
Sir Keir described small businesses as "the beating heart of driving growth and creating jobs for local people."
Released on Monday morning, the election manifesto shared by the Liberal Democrats pledges to "strengthen patients' rights" by tackling public health
inequalities and providing early access to community services.
The Liberal Democrats Party's manifesto promises to address the issues at both the "front and back doors" of the National Health Service (NHS), which the party
claims has been plunged into crisis by the Conservatives.
Pledging to invest in public health and early access to community services, the party aims to "work towards a fairer and more sustainable long-term funding model
for pharmacies and build on the Pharmacy First approach to give patients more accessible routine services and ease the pressure on GPs."
The pledge also includes making prescriptions for people with chronic mental health conditions free on the NHS, as part of a wider commitment to review the entire
schedule of exemptions for prescription charges.
As the general election campaign heats up, major political parties - including Labour, the Conservatives, the Liberal Democrats - have released their
manifestos, detailing their plans and visions for the future of community pharmacy.
While the Conservative Party promises to expand Pharmacy First initiative, Labour pledges support for small businesses, with plans to overhaul the business
rates system.
The Liberal Democrats' election manifesto commits to developing a fairer and more sustainable long-term funding model for pharmacies.
Announcing their plans recently, Prime Minister Rishi Sunak stated that they are investing in community care services to secure the future of the NHS and make
healthcare more accessible.
The Conservatives plan to fund these initiatives by cutting NHS managerial positions back to pre-pandemic levels and halving the government's management
consultancy expenditure.